Skip to content
OpenCapital
Get started

Merit Medical Systems MMSI EV / sales

EV / sales at other companies

Abbott logo
AbbottABT
4.6×-1.0×
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
2.7×-1.4×
TFX
TeleflexTFX
3.6×-1.0×
Johnson & Johnson logo
Johnson & JohnsonJNJ
6.5×+1.8×
Stryker logo
StrykerSYK
5.4×-1.3×
Boston Scientific logo
Boston ScientificBSX
7×-1.5×

Other financials

Income statement

See full
Revenue$381.9M+7.5%
Gross profit$184.8M+7.4%
Operating income$44.2M+7.6%
Net income$41.0M+36.0%
EPS (diluted)$0.68+38.8%

Balance sheet

See full
Cash & equivalents$488.1M+23.4%
Total debt$821.6M+0.5%
Total equity$1.6B+13.9%
Total assets$2.7B+10.2%

Cash flow

See full
Operating cash flow$40.7M+0.3%
CapEx$16.0M-24.0%
Free cash flow$24.7M+26.5%

Valuation

See full
Market cap$4.01B-34.1%

Profitability

See full
Gross margin48.7%+0.9pp
Operating margin12.2%+0.6pp
Net margin9%+0.2pp
FCF margin14.3%+1.3pp

Returns & leverage

See full
Return on equity9.1%0.0pp
Debt / equity0.5×-0.1×
Current ratio5.1×+0.2×

Where this comes from

Calculated from Merit Medical Systems’s reported figures.

enterprise value/total revenue=2.9×

Based on the most recent quarter.

The official record: Merit Medical Systems’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Merit Medical Systems's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Merit Medical Systems's EV / sales?
Merit Medical Systems (MMSI) reported EV / sales of 2.9× in Q1 2026.
How has Merit Medical Systems's EV / sales changed year-over-year?
Merit Medical Systems's EV / sales decreased by 40.0% year-over-year, from 4.8× to 2.9×.
What is the long-term trend for Merit Medical Systems's EV / sales?
Over 5 years (2020 to 2025), Merit Medical Systems's EV / sales has grown at a 0.3% compound annual growth rate (CAGR), from 3.6× to 3.7×.
What does EV / sales mean?
Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.